Company Profiles

driven by the PitchBook Platform

SynDevRx

SynDevRx
2007 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Early Stage VC LATEST DEAL TYPE (In Progress)
$17.8M LATEST DEAL AMOUNT
1 INVESTORS
Description

Developer of treatments designed to improve and save the lives of people worldwide. The company's treatments offer pre-clinical proof-of-concept models for both oncology and obesity as well as dyslipidemia and fatty liver diseases, that proposes to treat tumor directly and correct the underlying metabolic dysfunction, enabling patients to avail cure from metabo-oncology.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Biotechnology
Primary Office
One Broadway
14th Floor
Cambridge, MA 02142
United States

+1 (617) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore SynDevRx’s full profile, request a free trial.

SynDevRx Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC 25-Oct-2012 $17.8M 000.00 In Progress Profitable
3. Early Stage VC 20-Jul-2010 00.000 00.000 Completed Profitable
2. Early Stage VC (Series A) 23-Jul-2009 $570K $659K 00.000 Completed Profitable
1. Angel (individual) 27-Jan-2009 $89.5K $89.5K Completed Profitable
To view this company’s complete deal history including valuation and funding, request access »

SynDevRx Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series A 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
To view this company’s complete Cap Table, request access »

SynDevRx Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Translational Accelerator Accelerator/Incubator Minority 000 0000 000000 0

SynDevRx Executive Team (6)

Name Title Board
Seat
Contact
Info
Bradley Carver Co-Founder, President, Chief Executive Officer & Chairman
Neal Salomon MD Consulting Chief Medical Officer & Medical Monitor
James Shanahan Co-Founder, Vice President of Business Development & Board Member
Joanne Schindler MD Vice President, Clinical Development
David Neafus Consulting Chief Financial Officer

1 Former Executive

You’re viewing 5 of 6 executives. Get the full list »

SynDevRx Board Members (1)

Name Representing Role Since Contact
Info
Eric Tooker JD Translational Accelerator Board Member 000 0000
Questions or concerns about this profile? Reach out to website-support@pitchbook.com